Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2240
https://www.valueinhealthjournal.com/article/S1098-3015(16)33606-3/fulltext
Title :
Cost Minimization Analysis of Bevacizumab Versus Cetuximab and Panitumumab in the Management of Colorectal Cancer from Patient Perspective in Egypt
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33606-3&doi=10.1016/j.jval.2016.09.2240
First page :
A738
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2125